Vivozon Healthcare Inc - Asset Resilience Ratio
Vivozon Healthcare Inc (082800) has an Asset Resilience Ratio of 1.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Vivozon Healthcare Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Vivozon Healthcare Inc's Asset Resilience Ratio has changed over time. See Vivozon Healthcare Inc (082800) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Vivozon Healthcare Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Vivozon Healthcare Inc worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.98 Billion | 1.16% |
| Total Liquid Assets | ₩1.98 Billion | 1.16% |
Asset Resilience Insights
- Limited Liquidity: Vivozon Healthcare Inc maintains only 1.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Vivozon Healthcare Inc Industry Peers by Asset Resilience Ratio
Compare Vivozon Healthcare Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 65.38% |
|
Caregen Co.Ltd
KQ:214370 |
Pharmaceuticals | 4.58% |
|
Kolon Life Science Inc
KQ:102940 |
Pharmaceuticals | 1.22% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 13.09% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
Annual Asset Resilience Ratio for Vivozon Healthcare Inc (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Vivozon Healthcare Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.22% | ₩2.02 Billion ≈ $1.37 Million |
₩165.48 Billion ≈ $112.14 Million |
-0.66pp |
| 2024-12-31 | 1.88% | ₩3.46 Billion ≈ $2.35 Million |
₩184.45 Billion ≈ $125.00 Million |
-3.73pp |
| 2023-12-31 | 5.61% | ₩9.73 Billion ≈ $6.60 Million |
₩173.65 Billion ≈ $117.68 Million |
-2.31pp |
| 2022-12-31 | 7.91% | ₩14.80 Billion ≈ $10.03 Million |
₩187.07 Billion ≈ $126.78 Million |
-19.99pp |
| 2021-12-31 | 27.90% | ₩54.26 Billion ≈ $36.77 Million |
₩194.47 Billion ≈ $131.79 Million |
-8.64pp |
| 2020-12-31 | 36.54% | ₩90.68 Billion ≈ $61.45 Million |
₩248.16 Billion ≈ $168.17 Million |
-5.73pp |
| 2019-12-31 | 42.27% | ₩69.60 Billion ≈ $47.17 Million |
₩164.65 Billion ≈ $111.58 Million |
+9.90pp |
| 2018-12-31 | 32.37% | ₩32.58 Billion ≈ $22.08 Million |
₩100.65 Billion ≈ $68.21 Million |
+27.65pp |
| 2017-12-31 | 4.72% | ₩1.72 Billion ≈ $1.16 Million |
₩36.40 Billion ≈ $24.67 Million |
+0.41pp |
| 2016-12-31 | 4.31% | ₩1.81 Billion ≈ $1.23 Million |
₩41.96 Billion ≈ $28.44 Million |
+0.12pp |
| 2015-12-31 | 4.20% | ₩2.04 Billion ≈ $1.38 Million |
₩48.71 Billion ≈ $33.01 Million |
+0.46pp |
| 2014-12-31 | 3.74% | ₩2.00 Billion ≈ $1.36 Million |
₩53.54 Billion ≈ $36.28 Million |
+3.25pp |
| 2010-12-31 | 0.48% | ₩679.36 Million ≈ $460.39K |
₩140.22 Billion ≈ $95.02 Million |
+0.14pp |
| 2009-12-31 | 0.34% | ₩294.41 Million ≈ $199.52K |
₩86.69 Billion ≈ $58.75 Million |
-- |
About Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more